Argenta And BioFocus Have A New Home
On March 31st, we announced the acquisition of Argenta and BioFocus, global leaders in discovery services. The integration of the Early Discovery capabilities into the Charles River portfolio allows us to engage with clients as a full-service, early-stage CRO with unparalleled integrated in vitro and in vivo capabilities, from target discovery through preclinical development.
We are pleased to inform you that www.argentadiscovery.com and www.biofocus.com are now incorporated into the Charles River website, providing you with integrated discovery services information in a single location.
Please visit our site to learn more about our significantly enhanced capabilities in:
- Integrated Drug Discovery
- Assay Development and Screening
- Medicinal Chemistry
- In Vivo Pharmacology
- Pharmacology Database
As always, we value your feedback. If you have any questions or suggestions for making the site easier to navigate, please contact us at askcharlesriver@crl.com.